• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于钙化性主动脉瓣狭窄的新预测模型的开发与验证。

Development and validation of a new prediction model for calcific aortic valve stenosis.

作者信息

Chen Jun-Yu, Zhu Ming-Zhen, Xiong Tao, Wang Zi-Yao, Chang Qing

机构信息

Department of Cardiovascular Surgery, the Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.

Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan, China.

出版信息

J Thorac Dis. 2022 Oct;14(10):4044-4054. doi: 10.21037/jtd-22-1157.

DOI:10.21037/jtd-22-1157
PMID:36389293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9641316/
Abstract

BACKGROUND

Calcific aortic valve stenosis (CAVS) is a common valvular heart disease, but there are limited reports on the construction of prediction models for CAVS. This study aimed to investigate the risk factors for CAVS and construct a predictive model for CAVS based on its common clinical features.

METHODS

Patients with CAVS who underwent surgical treatment in our hospital from 2016 to 2020 and those who underwent physical examination during the same period were retrospectively studied and placed in the CAVS group and normal group based on the area of aortic valve orifice less than or more than 3 cm. A total of 548 patients were included in this study, including 106 CAVS patients and 442 normal patients. Subjects were randomly divided into training and validation sets at a 7:3 ratio. The features were dimensionally reduced using the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm in the training set, and the optimal clinical features were selected. The independent predictors of patients with CAVS were determined by univariate and multivariate logistic regression, and nomogram was constructed. The calibration curve, receiver operating characteristic (ROC) curve, and decision curve analysis (DCA) were used to evaluate the model in both the training set and the validation set.

RESULTS

In this study, 11 independent predictors were distinguished by multivariate logistic regression analysis: history of hypertension, history of carotid atherosclerosis, age, diastolic blood pressure, C-reactive protein, direct bilirubin, alkaline phosphatase, low-density lipoprotein (LDL), lipoprotein(a) [Lp(a)], uric acid, and cystatin C. A nomogram was constructed using the above indicators. The model was well-calibrated and showed good discrimination and accuracy [the area under the curve (AUC) =0.981] in the training set, with a sensitivity of 91.89% and a specificity of 95.48%. More importantly, the nomogram displayed a good performance in the validation set (AUC =0.955, 95% CI: 0.925-0.985), with a sensitivity of 93.75% and a specificity of 84.09%. Additionally, DCA revealed that the nomogram had high clinical practicability.

CONCLUSIONS

This study successfully established a risk prediction model for CAVS based on 11 conveniently accessible clinical indicators, which might easily be used for individualized risk assessment of CAVS.

摘要

背景

钙化性主动脉瓣狭窄(CAVS)是一种常见的心脏瓣膜疾病,但关于CAVS预测模型构建的报道有限。本研究旨在探讨CAVS的危险因素,并基于其常见临床特征构建CAVS预测模型。

方法

回顾性研究2016年至2020年在我院接受手术治疗的CAVS患者以及同期接受体检的患者,根据主动脉瓣口面积小于或大于3cm将其分为CAVS组和正常组。本研究共纳入548例患者,其中CAVS患者106例,正常患者442例。将受试者按7:3的比例随机分为训练集和验证集。在训练集中使用最小绝对收缩和选择算子(LASSO)算法对特征进行降维,选择最佳临床特征。通过单因素和多因素逻辑回归确定CAVS患者的独立预测因素,并构建列线图。使用校准曲线、受试者工作特征(ROC)曲线和决策曲线分析(DCA)在训练集和验证集中评估模型。

结果

本研究通过多因素逻辑回归分析鉴别出11个独立预测因素:高血压病史、颈动脉粥样硬化病史、年龄、舒张压、C反应蛋白、直接胆红素、碱性磷酸酶、低密度脂蛋白(LDL)、脂蛋白(a)[Lp(a)]、尿酸和胱抑素C。使用上述指标构建列线图。该模型在训练集中校准良好,具有良好的区分度和准确性[曲线下面积(AUC)=0.981],灵敏度为91.89%,特异度为95.48%。更重要的是,列线图在验证集中表现良好(AUC =0.955,95%CI:0.925 - 0.985),灵敏度为93.75%,特异度为84.09%。此外,DCA显示列线图具有较高的临床实用性。

结论

本研究成功基于11个易于获取的临床指标建立了CAVS风险预测模型,该模型可能易于用于CAVS的个体化风险评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/ebd8d238cd29/jtd-14-10-4044-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/44f0be12d8db/jtd-14-10-4044-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/9fbae7e7607c/jtd-14-10-4044-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/deaab7ffb7d0/jtd-14-10-4044-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/4c036c2952eb/jtd-14-10-4044-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/ebd8d238cd29/jtd-14-10-4044-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/44f0be12d8db/jtd-14-10-4044-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/9fbae7e7607c/jtd-14-10-4044-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/deaab7ffb7d0/jtd-14-10-4044-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/4c036c2952eb/jtd-14-10-4044-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c597/9641316/ebd8d238cd29/jtd-14-10-4044-f5.jpg

相似文献

1
Development and validation of a new prediction model for calcific aortic valve stenosis.一种用于钙化性主动脉瓣狭窄的新预测模型的开发与验证。
J Thorac Dis. 2022 Oct;14(10):4044-4054. doi: 10.21037/jtd-22-1157.
2
Epidemiological study of calcified aortic valve stenosis in a Chinese community population.中国社区人群钙化性主动脉瓣狭窄的流行病学研究。
Postgrad Med J. 2023 Jul 21;99(1174):868-874. doi: 10.1136/pmj-2022-141721.
3
Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis.脂蛋白(a)及其自身抗体与钙化性主动脉瓣狭窄的关系
Diseases. 2023 Mar 3;11(1):43. doi: 10.3390/diseases11010043.
4
Development and validation of a clinical prediction model for detecting coronary heart disease in middle-aged and elderly people: a diagnostic study.开发和验证一种用于检测中老年人心血管疾病的临床预测模型:一项诊断研究。
Eur J Med Res. 2023 Sep 25;28(1):375. doi: 10.1186/s40001-023-01233-0.
5
Construction and validation of a clinical prediction model for asymptomatic obstructive coronary stenosis in patients with carotid stenosis.颈动脉狭窄患者无症状性阻塞性冠状动脉狭窄临床预测模型的构建与验证
Front Cardiovasc Med. 2023 Sep 7;10:1096020. doi: 10.3389/fcvm.2023.1096020. eCollection 2023.
6
Development and validation of dynamic nomogram of frailty risk for older patients hospitalized with heart failure.老年心力衰竭住院患者衰弱风险动态列线图的开发与验证
Int J Nurs Sci. 2023 Mar 23;10(2):142-150. doi: 10.1016/j.ijnss.2023.03.014. eCollection 2023 Apr.
7
[Establishment and effect evaluation of nomogram model for diagnosis and prediction of pulmonary hypertension in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者肺动脉高压诊断与预测列线图模型的建立及效果评价]
Zhonghua Yi Xue Za Zhi. 2022 Oct 18;102(38):3019-3025. doi: 10.3760/cma.j.cn112137-20220512-01045.
8
Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors.基于 CT 图像和 3D 纹理分析的Nomogram 模型的建立及其在胃肠道间质瘤恶性潜能术前预测中的验证。
Cancer Imaging. 2020 Jan 13;20(1):5. doi: 10.1186/s40644-019-0284-7.
9
Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者支架内再狭窄风险预测列线图的建立与验证。
BMC Cardiovasc Disord. 2021 Sep 14;21(1):435. doi: 10.1186/s12872-021-02255-4.
10
Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population.非酒精性脂肪性肝病风险预测模型的开发与验证:一项基于体检人群的研究
Diabetes Metab Syndr Obes. 2024 Jan 8;17:143-155. doi: 10.2147/DMSO.S438652. eCollection 2024.

本文引用的文献

1
Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank.胆红素作为代谢心血管健康的指标:英国生物库的横断面分析。
Cardiovasc Diabetol. 2022 Apr 18;21(1):54. doi: 10.1186/s12933-022-01484-x.
2
Bioinformatics and Machine Learning Methods to Identify FN1 as a Novel Biomarker of Aortic Valve Calcification.用于鉴定FN1作为主动脉瓣钙化新生物标志物的生物信息学和机器学习方法
Front Cardiovasc Med. 2022 Feb 28;9:832591. doi: 10.3389/fcvm.2022.832591. eCollection 2022.
3
Bioinformatic-based Identification of Genes Associated with Aortic Valve Stenosis.
基于生物信息学的主动脉瓣狭窄相关基因鉴定。
Heart Surg Forum. 2022 Jan 24;25(1):E069-E078. doi: 10.1532/hsf.4263.
4
Endothelial cell-derived tetrahydrobiopterin prevents aortic valve calcification.内皮细胞衍生的四氢生物蝶呤可预防主动脉瓣钙化。
Eur Heart J. 2022 May 1;43(17):1652-1664. doi: 10.1093/eurheartj/ehac037.
5
Dyslipidemia and aortic valve disease.血脂异常与主动脉瓣疾病。
Curr Opin Lipidol. 2021 Dec 1;32(6):349-354. doi: 10.1097/MOL.0000000000000794.
6
Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.脂蛋白(a)、低密度脂蛋白胆固醇和高血压:家族性高胆固醇血症患者主动脉瓣置换的预测因素。
Eur Heart J. 2021 Jun 7;42(22):2201-2211. doi: 10.1093/eurheartj/ehaa1066.
7
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.
8
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
9
Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis.钙化性主动脉瓣狭窄药物治疗的当前证据与未来展望
Int J Mol Sci. 2020 Nov 4;21(21):8263. doi: 10.3390/ijms21218263.
10
CircRNA TGFBR2/MiR-25-3p/TWIST1 axis regulates osteoblast differentiation of human aortic valve interstitial cells.环状RNA TGFBR2/微小RNA-25-3p/TWIST1轴调控人主动脉瓣间质细胞的成骨细胞分化
J Bone Miner Metab. 2021 May;39(3):360-371. doi: 10.1007/s00774-020-01164-4. Epub 2020 Oct 18.